array:34 [ "id" => array:1 [ 0 => array:1 [ "value" => "5270" ] ] "isin" => array:1 [ 0 => array:1 [ "value" => "DE000LS9FPW6" ] ] "wkn" => array:1 [ 0 => array:1 [ "value" => "LS9FPW" ] ] "name" => array:1 [ 0 => array:1 [ "value" => "BIPHAGE" ] ] "short_description" => array:1 [ 0 => array:1 [ "value" => "Biotech, Pharmazie und Generika " ] ] "long_description" => array:1 [ 0 => array:1 [ "value" => """ Ziel dieses Portfolios ist es hauptsächlich in wachstumsstarke Unternehmen aus dem Biotechnologie- und Generikasektor zu investieren. \r\n Bei der Aktienauswahl sollen sowohl die fundamentalen Zahlen und Jahresberichte, als auch die Produktpalette und Pipeline untersucht werden. Investments sollen hauptsächlich in Aktien erfolgen. Falls sich jedoch zeitweilig keine interessanten Werte finden kann auch in Fonds oder ETF's der Biotechbranche, oder bei stark fallenden Märkten Short-ETF's auf Indizes investiert werden.\r\n Im Schnitt sollen etwa 10-20 Titel gehalten werden. \r\n \r\n """ ] ] "status" => array:1 [ 0 => array:1 [ "value" => "Investable" ] ] "trader_name" => array:1 [ 0 => array:1 [ "value" => "Enigma" ] ] "symbol" => array:1 [ 0 => array:1 [ "value" => "WF0BIPHAGE" ] ] "creation_date" => array:1 [ 0 => array:1 [ "value" => "1418319511" ] ] "issuing_date" => array:1 [ 0 => array:1 [ "value" => "1431912695" ] ] "daily_free_relative" => array:1 [ 0 => array:1 [ "value" => "0.95" ] ] "performance_free_relative" => array:1 [ 0 => array:1 [ "value" => "10" ] ] "cash" => array:1 [ 0 => array:1 [ "value" => "23517.6" ] ] "url" => array:1 [ 0 => array:1 [ "value" => "https://www.wikifolio.com/de/ch/w/wf0biphage" ] ] "href" => array:1 [ 0 => array:1 [ "value" => "https://api.wikifolio.com/api/v1/wikifolios/de000ls9fpw6" ] ] "wikifolio_tags" => array:1 [ 0 => array:1 [ "value" => "a:12:{i:0;a:3:{s:4:"Name";s:3:"etf";s:16:"ShortDescription";s:4:"ETFs";s:8:"TagGroup";s:15:"Anlageuniversum";}i:1;a:3:{s:4:"Name";s:6:"akteur";s:16:"ShortDescription";s:13:"Aktien Europa";s:8:"TagGroup";s:15:"Anlageuniversum";}i:2;a:3:{s:4:"Name";s:11:"fundamental";s:16:"ShortDescription";s:20:"Fundamentale Analyse";s:8:"TagGroup";s:20:"Entscheidungsfindung";}i:3;a:3:{s:4:"Name";s:5:"aktde";s:16:"ShortDescription";s:18:"Aktien Deutschland";s:8:"TagGroup";s:15:"Anlageuniversum";}i:4;a:3:{s:4:"Name";s:6:"divers";s:16:"ShortDescription";s:20:"Aktiv diversifiziert";s:8:"TagGroup";s:11:"Handelsstil";}i:5;a:3:{s:4:"Name";s:10:"schwer-usa";s:16:"ShortDescription";s:15:"Schwerpunkt USA";s:8:"TagGroup";s:35:"ExtendedSearchInvestmentRegionGroup";}i:6;a:3:{s:4:"Name";s:8:"sonstige";s:16:"ShortDescription";s:16:"Sonstige Analyse";s:8:"TagGroup";s:20:"Entscheidungsfindung";}i:7;a:3:{s:4:"Name";s:6:"aktint";s:16:"ShortDescription";s:20:"Aktien International";s:8:"TagGroup";s:15:"Anlageuniversum";}i:8;a:3:{s:4:"Name";s:6:"akthot";s:16:"ShortDescription";s:17:"Aktien Hot Stocks";s:8:"TagGroup";s:15:"Anlageuniversum";}i:9;a:3:{s:4:"Name";s:5:"fonds";s:16:"ShortDescription";s:5:"Fonds";s:8:"TagGroup";s:15:"Anlageuniversum";}i:10;a:3:{s:4:"Name";s:6:"aktusa";s:16:"ShortDescription";s:10:"Aktien USA";s:8:"TagGroup";s:15:"Anlageuniversum";}i:11;a:3:{s:4:"Name";s:8:"techanal";s:16:"ShortDescription";s:18:"Technische Analyse";s:8:"TagGroup";s:20:"Entscheidungsfindung";}}" ] ] "rankings" => array:1 [ 0 => array:1 [ "value" => "a:8:{i:0;a:4:{s:4:"Name";s:3:"aum";s:16:"ShortDescription";s:19:"Summe Investitionen";s:5:"Value";d:1439.408063;s:5:"Index";i:3566;}i:1;a:4:{s:4:"Name";s:8:"topwikis";s:16:"ShortDescription";s:23:"Top-wikifolio-Rangliste";s:5:"Value";d:6.917730051312;s:5:"Index";i:8175;}i:2;a:4:{s:4:"Name";s:6:"perf1m";s:16:"ShortDescription";s:19:"Performance 1 Monat";s:5:"Value";d:0;s:5:"Index";i:28484;}i:3;a:4:{s:4:"Name";s:7:"perf12m";s:16:"ShortDescription";s:18:"Performance 1 Jahr";s:5:"Value";d:7.149930819;s:5:"Index";i:25098;}i:4;a:4:{s:4:"Name";s:8:"perfever";s:16:"ShortDescription";s:23:"Performance seit Beginn";s:5:"Value";d:-28.029596861796;s:5:"Index";i:87734;}i:5;a:4:{s:4:"Name";s:6:"perf3m";s:16:"ShortDescription";s:20:"Performance 3 Monate";s:5:"Value";d:0.71969105;s:5:"Index";i:31400;}i:6;a:4:{s:4:"Name";s:6:"perf6m";s:16:"ShortDescription";s:20:"Performance 6 Monate";s:5:"Value";d:-2.807466926;s:5:"Index";i:51373;}i:7;a:4:{s:4:"Name";s:7:"maxdraw";s:16:"ShortDescription";s:26:"maximaler Verlust (bisher)";s:5:"Value";d:-53.7116300009;s:5:"Index";i:81905;}}" ] ] "wikifolio_items" => array:1 [ 0 => array:1 [ "value" => "a:36:{i:0;a:8:{s:4:"ISIN";s:12:"DE000A4BGGM7";s:3:"WKN";s:6:"A4BGGM";s:16:"ShortDescription";s:25:"BIOFRONTERA AG NA ON KONV";s:13:"AbsoluteValue";d:58.30569;s:13:"RelativeValue";d:0.002479237354633537;s:12:"AbsoluteGain";d:-3087.1943100000008;s:12:"RelativeGain";d:-0.9814637768240343;s:8:"Quantity";d:25.461;}i:1;a:8:{s:4:"ISIN";s:12:"DE000A1EWVY8";s:3:"WKN";s:6:"A1EWVY";s:16:"ShortDescription";s:11:"FORMYCON AG";s:13:"AbsoluteValue";d:19.58;s:13:"RelativeValue";d:0.0008325682691299023;s:12:"AbsoluteGain";d:-16.42;s:12:"RelativeGain";d:-0.45611111111111113;s:8:"Quantity";d:1;}i:2;a:8:{s:4:"ISIN";s:12:"DE000A1MMCC8";s:3:"WKN";s:6:"A1MMCC";s:16:"ShortDescription";s:15:"MEDIOS AG O.N.";s:13:"AbsoluteValue";d:12.5;s:13:"RelativeValue";d:0.0005315170257468733;s:12:"AbsoluteGain";d:-8.59;s:12:"RelativeGain";d:-0.40730203888098626;s:8:"Quantity";d:1;}i:3;a:8:{s:4:"ISIN";s:12:"CH0334081137";s:3:"WKN";s:6:"A2AT0Z";s:16:"ShortDescription";s:25:"CRISPR THERAPEUT. SF -,03";s:13:"AbsoluteValue";d:2787.9;s:13:"RelativeValue";d:0.11854530528637665;s:12:"AbsoluteGain";d:557.78342800782;s:12:"RelativeGain";d:0.25011402319186743;s:8:"Quantity";d:60;}i:4;a:8:{s:4:"ISIN";s:12:"CNE100000FN7";s:3:"WKN";s:6:"A0N99U";s:16:"ShortDescription";s:30:"SINOPHARM MEDICINE HOLDING CO.";s:13:"AbsoluteValue";d:1.837;s:13:"RelativeValue";d:7.81117421037605E-5;s:12:"AbsoluteGain";d:-2.305703773163;s:12:"RelativeGain";d:-0.5565697909900446;s:8:"Quantity";d:1;}i:5;a:8:{s:4:"ISIN";s:12:"CA1380357048";s:3:"WKN";s:6:"A3E2FV";s:16:"ShortDescription";s:13:"CANOPY GROWTH";s:13:"AbsoluteValue";d:0.0834;s:13:"RelativeValue";d:3.5462815957831384E-6;s:12:"AbsoluteGain";d:-24.419511561915;s:12:"RelativeGain";d:-0.9965963228578261;s:8:"Quantity";d:0.1;}i:6;a:8:{s:4:"ISIN";s:12:"CA05335P1099";s:3:"WKN";s:6:"A2JNSX";s:16:"ShortDescription";s:18:"AUXLY CANNABIS GRP";s:13:"AbsoluteValue";d:0.1066;s:13:"RelativeValue";d:4.532777195569335E-6;s:12:"AbsoluteGain";N;s:12:"RelativeGain";N;s:8:"Quantity";d:1;}i:7;a:8:{s:4:"ISIN";s:12:"BE0003818359";s:3:"WKN";s:6:"A0EAT9";s:16:"ShortDescription";s:25:"LAKEFRONT BIOTHERAPEUTICS";s:13:"AbsoluteValue";d:24.52;s:13:"RelativeValue";d:0.0010426237977050666;s:12:"AbsoluteGain";d:-61.796741545894;s:12:"RelativeGain";d:-0.7159299625905956;s:8:"Quantity";d:1;}i:8;a:8:{s:4:"ISIN";s:12:"SE0000872095";s:3:"WKN";s:6:"A0LA5K";s:16:"ShortDescription";s:24:"SWEDISH ORPHAN BIOVITRUM";s:13:"AbsoluteValue";d:40;s:13:"RelativeValue";d:0.0017008544823899946;s:12:"AbsoluteGain";d:22.208;s:12:"RelativeGain";d:1.2482014388489209;s:8:"Quantity";d:1;}i:9;a:8:{s:4:"ISIN";s:12:"US0042251084";s:3:"WKN";s:6:"603035";s:16:"ShortDescription";s:25:"ACADIA PHARMACEUT. DL-,01";s:13:"AbsoluteValue";d:18.765;s:13:"RelativeValue";d:0.0007979133590512062;s:12:"AbsoluteGain";d:-19.816;s:12:"RelativeGain";d:-0.5136206941240506;s:8:"Quantity";d:1;}i:10;a:8:{s:4:"ISIN";s:12:"US00847X1046";s:3:"WKN";s:6:"A1W2RM";s:16:"ShortDescription";s:25:"AGIOS PHARMACEUT. DL-,001";s:13:"AbsoluteValue";d:3700;s:13:"RelativeValue";d:0.1573290396210745;s:12:"AbsoluteGain";d:-1700.5;s:12:"RelativeGain";d:-0.31487825201370245;s:8:"Quantity";d:125;}i:11;a:8:{s:4:"ISIN";s:12:"US02043Q1076";s:3:"WKN";s:6:"A0CBCK";s:16:"ShortDescription";s:25:"ALNYLAM PHARMACE.DL-,0001";s:13:"AbsoluteValue";d:239.5;s:13:"RelativeValue";d:0.010183866213310092;s:12:"AbsoluteGain";d:151.418;s:12:"RelativeGain";d:1.7190572421153016;s:8:"Quantity";d:1;}i:12;a:8:{s:4:"ISIN";s:12:"DK0010272202";s:3:"WKN";s:6:"565131";s:16:"ShortDescription";s:6:"GENMAB";s:13:"AbsoluteValue";d:4412;s:13:"RelativeValue";d:0.18760424940761639;s:12:"AbsoluteGain";d:1152.16666666666;s:12:"RelativeGain";d:0.35344342757809427;s:8:"Quantity";d:20;}i:13;a:8:{s:4:"ISIN";s:12:"IE00B4Q5ZN47";s:3:"WKN";s:6:"A1JS1K";s:16:"ShortDescription";s:25:"JAZZ PHARMACEUT. DL-,0001";s:13:"AbsoluteValue";d:195.4;s:13:"RelativeValue";d:0.008308674146475124;s:12:"AbsoluteGain";d:57.707;s:12:"RelativeGain";d:0.4190990101167089;s:8:"Quantity";d:1;}i:14;a:8:{s:4:"ISIN";s:12:"US91324P1021";s:3:"WKN";s:6:"869561";s:16:"ShortDescription";s:25:"UNITEDHEALTH GROUP DL-,01";s:13:"AbsoluteValue";d:348.2;s:13:"RelativeValue";d:0.014805938269204903;s:12:"AbsoluteGain";d:242.766666666667;s:12:"RelativeGain";d:2.3025608599431022;s:8:"Quantity";d:1;}i:15;a:8:{s:4:"ISIN";s:12:"US92532F1003";s:3:"WKN";s:6:"882807";s:16:"ShortDescription";s:25:"VERTEX PHARMAC. DL-,01";s:13:"AbsoluteValue";d:3924.5;s:13:"RelativeValue";d:0.16687508540348833;s:12:"AbsoluteGain";d:2698.06130058757;s:12:"RelativeGain";d:2.199915333624236;s:8:"Quantity";d:10;}i:16;a:8:{s:4:"ISIN";s:12:"US2183521028";s:3:"WKN";s:6:"529882";s:16:"ShortDescription";s:25:"CORCEPT THERAPEUTICS INC.";s:13:"AbsoluteValue";d:69.52;s:13:"RelativeValue";d:0.0029560850903938103;s:12:"AbsoluteGain";d:55.751484131966;s:12:"RelativeGain";d:4.0492007029895465;s:8:"Quantity";d:1;}i:17;a:8:{s:4:"ISIN";s:12:"US1101221083";s:3:"WKN";s:6:"850501";s:16:"ShortDescription";s:25:"BRISTOL-MYERS SQUIBBDL-10";s:13:"AbsoluteValue";d:3751.6;s:13:"RelativeValue";d:0.1595231419033576;s:12:"AbsoluteGain";d:11.2;s:12:"RelativeGain";d:0.0029943321569885573;s:8:"Quantity";d:80;}i:18;a:8:{s:4:"ISIN";s:12:"US09075V1026";s:3:"WKN";s:6:"A2PSR2";s:16:"ShortDescription";s:24:"BIONTECH SE SPON. ADRS 1";s:13:"AbsoluteValue";d:3160;s:13:"RelativeValue";d:0.13436750410880957;s:12:"AbsoluteGain";d:-173.6;s:12:"RelativeGain";d:-0.05207583393328534;s:8:"Quantity";d:40;}i:19;a:8:{s:4:"ISIN";s:12:"US07725L1026";s:3:"WKN";s:6:"A1437N";s:16:"ShortDescription";s:18:"BEIGENE LTD SP.ADR";s:13:"AbsoluteValue";d:234;s:13:"RelativeValue";d:0.009949998721981467;s:12:"AbsoluteGain";d:132.299;s:12:"RelativeGain";d:1.300862331737151;s:8:"Quantity";d:1;}i:20;a:8:{s:4:"ISIN";s:12:"US09061G1013";s:3:"WKN";s:6:"924801";s:16:"ShortDescription";s:8:"BIOMARIN";s:13:"AbsoluteValue";d:47.51;s:13:"RelativeValue";d:0.002020189911458716;s:12:"AbsoluteGain";d:-43.568048780488;s:12:"RelativeGain";d:-0.4783594879760067;s:8:"Quantity";d:1;}i:21;a:8:{s:4:"ISIN";s:12:"US53220K5048";s:3:"WKN";s:6:"A1C9RN";s:16:"ShortDescription";s:27:"LIGAND PHARMACEUTICALS INC.";s:13:"AbsoluteValue";d:1190;s:13:"RelativeValue";d:0.050600420851102335;s:12:"AbsoluteGain";d:621.977916666665;s:12:"RelativeGain";d:1.0949889712327732;s:8:"Quantity";d:5;}i:22;a:8:{s:4:"ISIN";s:12:"US4523271090";s:3:"WKN";s:6:"927079";s:16:"ShortDescription";s:25:"ILLUMINA INC. DL-,01";s:13:"AbsoluteValue";d:1409.2;s:13:"RelativeValue";d:0.059921103414599504;s:12:"AbsoluteGain";d:-223.1192;s:12:"RelativeGain";d:-0.1366884614234765;s:8:"Quantity";d:10;}i:23;a:8:{s:4:"ISIN";s:12:"US4622601007";s:3:"WKN";s:6:"A2DT49";s:16:"ShortDescription";s:25:"IOVANCE BIOTHERAP.DL-,001";s:13:"AbsoluteValue";d:678;s:13:"RelativeValue";d:0.028829483476510407;s:12:"AbsoluteGain";d:-3176;s:12:"RelativeGain";d:-0.8240788790866632;s:8:"Quantity";d:200;}i:24;a:8:{s:4:"ISIN";s:12:"US31572Q8814";s:3:"WKN";s:6:"A419WK";s:16:"ShortDescription";s:25:"KYNTRA BIO INC. NEW O.N.";s:13:"AbsoluteValue";d:0.232;s:13:"RelativeValue";d:9.864955997861968E-6;s:12:"AbsoluteGain";d:-42.049947712418;s:12:"RelativeGain";d:-0.9945130247646595;s:8:"Quantity";d:0.04;}i:25;a:8:{s:4:"ISIN";s:12:"US29089Q1058";s:3:"WKN";s:6:"A0LC2W";s:16:"ShortDescription";s:25:"EMERGENT BIOSOLNS DL-,001";s:13:"AbsoluteValue";d:761.75;s:13:"RelativeValue";d:0.03239064754901446;s:12:"AbsoluteGain";d:-4647.32499999999;s:12:"RelativeGain";d:-0.8591718547071354;s:8:"Quantity";d:110;}i:26;a:8:{s:4:"ISIN";s:12:"US28106W1036";s:3:"WKN";s:6:"A2AC4K";s:16:"ShortDescription";s:25:"EDITAS MEDICINE DL-,0001";s:13:"AbsoluteValue";d:2.32;s:13:"RelativeValue";d:9.864955997861968E-5;s:12:"AbsoluteGain";d:-25.958;s:12:"RelativeGain";d:-0.917957422731452;s:8:"Quantity";d:1;}i:27;a:8:{s:4:"ISIN";s:12:"US30161Q1040";s:3:"WKN";s:6:"936718";s:16:"ShortDescription";s:25:"EXELIXIS INC. DL-,01";s:13:"AbsoluteValue";d:4509.5;s:13:"RelativeValue";d:0.191750082208442;s:12:"AbsoluteGain";d:2931.5;s:12:"RelativeGain";d:1.8577313054499367;s:8:"Quantity";d:100;}i:28;a:8:{s:4:"ISIN";s:12:"US58155Q1031";s:3:"WKN";s:6:"893953";s:16:"ShortDescription";s:25:"MCKESSON DL-,01";s:13:"AbsoluteValue";d:653.4;s:13:"RelativeValue";d:0.02778345796984056;s:12:"AbsoluteGain";d:474.303;s:12:"RelativeGain";d:2.6483023166217188;s:8:"Quantity";d:1;}i:29;a:8:{s:4:"ISIN";s:12:"US60770K1079";s:3:"WKN";s:6:"A2N9D9";s:16:"ShortDescription";s:25:"MODERNA INC. DL-,0001";s:13:"AbsoluteValue";d:2226;s:13:"RelativeValue";d:0.0946525519450032;s:12:"AbsoluteGain";d:-506.4;s:12:"RelativeGain";d:-0.18533157663592445;s:8:"Quantity";d:40;}i:30;a:8:{s:4:"ISIN";s:12:"US64125C1099";s:3:"WKN";s:6:"900964";s:16:"ShortDescription";s:27:"NEUROCRINE BIOSCIENCES INC.";s:13:"AbsoluteValue";d:6885;s:13:"RelativeValue";d:0.2927595777813778;s:12:"AbsoluteGain";d:2995;s:12:"RelativeGain";d:0.7699228791773779;s:8:"Quantity";d:50;}i:31;a:8:{s:4:"ISIN";s:12:"US8006771062";s:3:"WKN";s:6:"936386";s:16:"ShortDescription";s:25:"SANGAMO THERAP.INC.DL-,01";s:13:"AbsoluteValue";N;s:13:"RelativeValue";N;s:12:"AbsoluteGain";N;s:12:"RelativeGain";N;s:8:"Quantity";d:500;}i:32;a:8:{s:4:"ISIN";s:12:"US8101861065";s:3:"WKN";s:6:"883369";s:16:"ShortDescription";s:25:"SCOTTS MIRAC.GRO A DL-,01";s:13:"AbsoluteValue";d:56.24;s:13:"RelativeValue";d:0.0023914014022403322;s:12:"AbsoluteGain";d:-34.616;s:12:"RelativeGain";d:-0.3809985031258255;s:8:"Quantity";d:1;}i:33;a:8:{s:4:"ISIN";s:12:"US7599161095";s:3:"WKN";s:6:"870980";s:16:"ShortDescription";s:25:"REPLIGEN CORP. DL-,01";s:13:"AbsoluteValue";d:6894;s:13:"RelativeValue";d:0.29314227003991555;s:12:"AbsoluteGain";d:2274;s:12:"RelativeGain";d:0.4922077922077922;s:8:"Quantity";d:60;}i:34;a:8:{s:4:"ISIN";s:12:"US75886F1075";s:3:"WKN";s:6:"881535";s:16:"ShortDescription";s:25:"REGENERON PHARMAC.DL-,001";s:13:"AbsoluteValue";d:2654.5;s:13:"RelativeValue";d:0.11287295558760602;s:12:"AbsoluteGain";d:1058.98947368421;s:12:"RelativeGain";d:0.6637307972699708;s:8:"Quantity";d:5;}i:35;a:8:{s:4:"ISIN";s:12:"US74834L1008";s:3:"WKN";s:6:"904533";s:16:"ShortDescription";s:25:"QUEST DIAGNOSTICS DL-,01";s:13:"AbsoluteValue";d:168.45;s:13:"RelativeValue";d:0.007162723438964865;s:12:"AbsoluteGain";d:104.63;s:12:"RelativeGain";d:1.6394547163898465;s:8:"Quantity";d:1;}}" ] ] "licence_switzerland" => array:1 [ 0 => array:1 [ "value" => "0" ] ] "perf1m" => array:1 [ 0 => array:1 [ "value" => "0" ] ] "perf12m" => array:1 [ 0 => array:1 [ "value" => "7.14993" ] ] "perfever" => array:1 [ 0 => array:1 [ "value" => "-28.0296" ] ] "aum" => array:1 [ 0 => array:1 [ "value" => "1439.41" ] ] "topwikis" => array:1 [ 0 => array:1 [ "value" => "8175" ] ] "created" => array:1 [ 0 => array:1 [ "value" => "1649766873" ] ] "changed" => array:1 [ 0 => array:1 [ "value" => "1781817668" ] ] "solid_valor" => array:1 [ 0 => array:1 [ "value" => "28282105" ] ] "solid_bc" => array:1 [ 0 => array:1 [ "value" => "LSD" ] ] "solid_bc_id" => array:1 [ 0 => array:1 [ "value" => "2913" ] ] "solid_cc" => array:1 [ 0 => array:1 [ "value" => "EUR" ] ] "solid_cc_id" => array:1 [ 0 => array:1 [ "value" => "814" ] ] "fullquote_link" => array:1 [ 0 => array:1 [ "value" => "wikifolio/wf0biphage-lgsz-zt-28282105/lsd/eur" ] ] "solid_changed" => array:1 [ 0 => array:1 [ "value" => "1661258840" ] ] ]